FeesSafety
Pluang+

Immunic appoints Jaa Roberson as Chief People Officer ahead of key Phase 3 MS trial readout.

Market News
19 Oct 2026, 15:47 WIB
Proactive Investors
View Source
Bullish
Immunic appoints Jaa Roberson as Chief People Officer ahead of key Phase 3 MS trial readout.

Immunic Inc has named Jaa Roberson as its first Chief People Officer to strengthen its leadership team as it prepares for a pivotal Phase 3 multiple sclerosis trial readout by the end of 2026. Roberson will lead global talent and organizational strategy, supporting potential regulatory filings and commercialization of vidofludimus calcium. Her extensive HR experience, including scaling biopharma companies, aligns with Immunic's goal to build a strong MS-focused organization.

Immunic's leadership update provides context for readers following health-sector stocks. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 19, 2026 18:43 WIB: out of 150 priced US health stocks, 68 rose and 54 fell today. Among notable movers, Twist Bioscience Corp (TWST) rose 1.74% to USD 135.06 with a typical hold time of 27 days, Hims and Hers Health Inc (HIMS) increased 1.46% to USD 28.48 with a 22-day hold, and BrightSpring Health Services Inc (BTSG) gained 1.40% to USD 61.72 with a 10-day hold.

More News

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

Coupang leads South Korea's e-commerce with strong logistics but faces losses and regulatory challenges, including a major data breach. DICK'S Sporting Goods, expanding through Foot Locker acquisition, shows strong profitability, a solid dividend, an...

Market News
Neutral
21 minutes ago
AMD stock soars 140% in 2026, Nvidia lags but both poised for strong earnings growth by 2028.

AMD stock soars 140% in 2026, Nvidia lags but both poised for strong earnings growth by 2028.

In 2026, AMD's stock surged 140% due to strong growth in AI chips and server CPUs, with revenue and earnings expected to continue rising sharply through 2028. Nvidia, despite a 20% stock drop and leadership uncertainty, reported impressive revenue an...

Market News
Neutral
30 minutes ago
Berkshire Hathaway valued at $700 per share, driven by cash, stocks, and growing businesses under CEO Greg Abel.

Berkshire Hathaway valued at $700 per share, driven by cash, stocks, and growing businesses under CEO Greg Abel.

Berkshire Hathaway holds $352 billion in cash and Treasury bills and a $336 billion stock portfolio, covering over half its current share price. CEO Greg Abel's patient management and steady growth in operating businesses, including railroad and util...

Market News
Bullish
51 minutes ago
Gilead raises dividend for 11th year, backed by strong cash flow and expanding drug portfolio.

Gilead raises dividend for 11th year, backed by strong cash flow and expanding drug portfolio.

Gilead Sciences increased its dividend by 3.8% for the 11th consecutive year, supported by strong free cash flow of $10.6 billion over nine months and a conservative payout ratio below 30%. The company maintains a dominant position in HIV therapies w...

Company Fundamentals
Bullish
1 hour ago
Nvidia stock plunges 23% amid CEO resignation and investigations, trading at a record low P/E of 8.

Nvidia stock plunges 23% amid CEO resignation and investigations, trading at a record low P/E of 8.

Nvidia experienced its worst week since 2008, dropping 23% following CEO Jensen Huang's resignation and multiple investigations into chip exports to China. Despite a strong earnings report showing 103% revenue growth and raised guidance, the stock tr...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App